Brainard Diana has filed 21 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 8000 shares of NEKTAR THERAPEUTICS ($NKTR) on September 30, 2025.
Activity breakdown: 0 open-market purchases and 19 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2025 | NEKTAR THERAPEUTICS | $NKTR | Brainard Diana | Not found | A | Stock Option | 8000 | $0.00 | 8,000.0000 | 205,661,000 | 9999.99% | 0.00% |
| Sept. 18, 2024 | NEKTAR THERAPEUTICS | $NKTR | Brainard Diana | Not found | A | Stock Option | 120000 | $0.00 | 120,000.0000 | 190,001,000 | 9999.99% | 0.06% |
| Nov. 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 8706 | $0.55 | 723,363.0000 | 0 | 1.19% | 0.00% |
| Nov. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 10609 | $0.86 | 732,069.0000 | 0 | 1.43% | 0.00% |
| Oct. 21, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 9752 | $0.78 | 742,678.0000 | 0 | 1.30% | 0.00% |
| Oct. 3, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 1493 | $0.81 | 752,430.0000 | 0 | 0.20% | 0.00% |
| Aug. 20, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 5390 | $0.74 | 753,923.0000 | 0 | 0.71% | 0.00% |
| Aug. 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 3091 | $0.76 | 759,313.0000 | 0 | 0.41% | 0.00% |
| Aug. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 10847 | $0.73 | 762,404.0000 | 0 | 1.40% | 0.00% |
| July 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 9731 | $0.75 | 773,251.0000 | 0 | 1.24% | 0.00% |
| July 2, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 1489 | $0.72 | 782,982.0000 | 0 | 0.19% | 0.00% |
| May 21, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 5149 | $0.79 | 784,471.0000 | 0 | 0.65% | 0.00% |
| May 17, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 3075 | $0.75 | 789,620.0000 | 0 | 0.39% | 0.00% |
| May 3, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 10240 | $0.80 | 792,695.0000 | 0 | 1.28% | 0.00% |
| April 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 9601 | $0.75 | 802,935.0000 | 0 | 1.18% | 0.00% |
| April 2, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 1533 | $0.77 | 812,536.0000 | 0 | 0.19% | 0.00% |
| Feb. 20, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 3097 | $0.70 | 819,224.0000 | 0 | 0.38% | 0.00% |
| Feb. 21, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 5155 | $0.71 | 814,069.0000 | 0 | 0.63% | 0.00% |
| Feb. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 41421 | $0.67 | 822,321.0000 | 0 | 4.80% | 0.00% |
| Jan. 23, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 9500 | $0.67 | 863,742.0000 | 0 | 1.09% | 0.00% |
| Jan. 4, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Brainard Diana | Chief Executive Officer | S | Common Stock | 1664 | $0.64 | 873,242.0000 | 0 | 0.19% | 0.00% |